Eloxx Pharmaceuticals, Inc.
ELOX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $4 | $50 | $159 | $280 |
| - Cash | $19 | $42 | $25 | $22 |
| + Debt | $13 | $13 | $12 | $16 |
| Enterprise Value | -$2 | $21 | $147 | $273 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$32 | -$65 | -$33 | -$49 |
| % Margin | – | – | – | – |
| Net Income | -$36 | -$67 | -$35 | -$51 |
| % Margin | – | – | – | – |
| EPS Diluted | -16.65 | -38.15 | -34.47 | -53.46 |
| % Growth | 56.4% | -10.7% | 35.5% | – |
| Operating Cash Flow | -$32 | -$35 | -$28 | -$39 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$32 | -$35 | -$28 | -$39 |